Search for Video Filter by category
Date Added Most Popular
All Videos Educational Technical Support Products Customer
Tumor Evolution in the Transcriptome, Epigenome, and Epitranscriptome

1169 views | 1 decade ago

Christopher Mason, Assistant Professor in the Department of Physiology and Biomedicine at the Weill Cornell Medical College, describes how tumor evolution can be tracked by sequencing the transcriptome,...

Illumina's Genomic Technologies: Applications in Cancer Research and Translation

484 views | 1 decade ago

Jennifer Stone, Ph.D., Cancer Genomics Market Manager at Illumina, discusses Illumina's view of cancer research and how by continually advancing its technologies it is supporting researchers with tools...

Illumina NextGen Sequencing: Think Big, Start Small

8157 views | 1 decade ago

Kenneth Bloom, MD, FCAP, Chief Medical Officer at Clarient (GE Healthcare), discusses the practical aspects of how next-generation sequencing will be applied in the clinical laboratory.

Using LymphoTrack DeepSeq Assays on Illumina MiSeq to Identify and Track Clonal Cell Populations

753 views | 1 decade ago

Jeffrey Miller, Ph.D., CSO and CEO of Invivoscribe, discusses the clinical basis for clonality testing, current technologies to identify clonality and the development of new assays to identify and monitor...

Sequencing analysis of cancer tissue samples: FFPE vs.Fresh Frozen

1831 views | 1 decade ago

Illumina Cancer Webinar Series: Gad Getz, Ph.D., founder of the Cancer Genome Computational Analysis group at the Broad Institute and Director of Bioinformatics at the Mass General Cancer Center and...

Considerations for the Development of an Autism Targeted Sequencing Panel with Dr. Jonathan Pevsner

199 views | 1 decade ago

Considerations for the Development of an Autism Targeted Sequencing Panel with Dr. Jonathan Pevsner

STORY -- A Pivotal Autism Clinical Trial Utilizing Illumina Next Generation Sequencing

1391 views | 1 decade ago

SynapDx is developing a test to shorten the time from suspicion of autism to diagnosis. They chose Illumina next-generation sequencing technology as the platform for designing performance characteristics...

Discovering a Causal Somatic Mutation in Patients with Sturge-Weber

436 views | 1 decade ago

Discovering a Causal Somatic Mutation in Patients with Sturge-Weber Syndrome with Dr. Jonathan Pevsner

For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.